Drug
Bayer Aspirin Extra Strength
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Upper Gastrointestinal Haemorrhage | 63 | 19.9 | 20.2 | signal |
| 2 | Gastric Haemorrhage | 34 | 15.6 | 15.8 | signal |
| 3 | Internal Haemorrhage | 33 | 15.3 | 15.5 | signal |
| 4 | Gastrointestinal Haemorrhage | 226 | 14.3 | 15.1 | signal |
| 5 | Incorrect Drug Administration Duration | 67 | 12.5 | 12.7 | signal |
| 6 | Rectal Haemorrhage | 68 | 8.4 | 8.5 | signal |
| 7 | Gastric Ulcer | 30 | 8.4 | 8.4 | signal |
| 8 | Product Prescribing Issue | 26 | 6.8 | 6.8 | signal |
| 9 | Expired Product Administered | 40 | 6.4 | 6.5 | signal |
| 10 | Increased Tendency To Bruise | 11 | 6.3 | 6.4 | signal |
| 11 | Product Use Complaint | 18 | 6.2 | 6.2 | signal |
| 12 | End Stage Renal Disease | 21 | 6.1 | 6.1 | signal |
| 13 | Hair Colour Changes | 14 | 5.9 | 5.9 | signal |
| 14 | Product Use Issue | 208 | 5.9 | 6.2 | signal |
| 15 | Hiatus Hernia | 14 | 5.7 | 5.8 | signal |
| 16 | Epistaxis | 79 | 5.6 | 5.7 | signal |
| 17 | Drug Administration Error | 32 | 5.5 | 5.5 | signal |
| 18 | Post Procedural Haemorrhage | 12 | 5.5 | 5.5 | signal |
| 19 | Haematuria | 35 | 5.4 | 5.5 | signal |
| 20 | Body Height Decreased | 11 | 5.4 | 5.4 | signal |
| 21 | Ulcer | 16 | 5.3 | 5.4 | signal |
| 22 | Haemorrhage Intracranial | 15 | 5.3 | 5.3 | signal |
| 23 | Drug Hypersensitivity | 194 | 5.3 | 5.5 | signal |
| 24 | Madarosis | 11 | 5.0 | 5.0 | signal |
| 25 | Incorrect Product Administration Duration | 19 | 5.0 | 5.0 | signal |
| 26 | Therapeutic Response Unexpected | 42 | 5.0 | 5.0 | signal |
| 27 | Choking | 18 | 4.9 | 4.9 | signal |
| 28 | Chronic Kidney Disease | 70 | 4.9 | 4.9 | signal |
| 29 | Subdural Haematoma | 13 | 4.8 | 4.8 | signal |
| 30 | Hair Texture Abnormal | 12 | 4.7 | 4.7 | signal |
| 31 | Product Use In Unapproved Indication | 214 | 4.7 | 4.9 | signal |
| 32 | Blood Urine Present | 16 | 4.5 | 4.5 | signal |
| 33 | Macular Degeneration | 10 | 4.5 | 4.5 | signal |
| 34 | Hyperlipidaemia | 10 | 4.4 | 4.4 | signal |
| 35 | Eye Haemorrhage | 11 | 4.4 | 4.4 | signal |
| 36 | Drug Prescribing Error | 16 | 4.4 | 4.4 | signal |
| 37 | Nerve Injury | 9 | 4.3 | 4.3 | signal |
| 38 | Sneezing | 18 | 4.3 | 4.3 | signal |
| 39 | Haemorrhage | 83 | 4.2 | 4.3 | signal |
| 40 | Haemoptysis | 22 | 4.2 | 4.2 | signal |
| 41 | Faeces Discoloured | 17 | 4.2 | 4.2 | signal |
| 42 | Melaena | 17 | 4.1 | 4.1 | signal |
| 43 | Pulmonary Congestion | 10 | 4.0 | 4.0 | signal |
| 44 | Nephropathy | 7 | 4.0 | 4.0 | signal |
| 45 | Malignant Melanoma | 10 | 4.0 | 4.0 | signal |
| 46 | Squamous Cell Carcinoma | 7 | 3.9 | 4.0 | signal |
| 47 | Intentional Product Misuse | 63 | 3.9 | 3.9 | signal |
| 48 | Coagulopathy | 12 | 3.8 | 3.8 | signal |
| 49 | Haematemesis | 18 | 3.8 | 3.8 | signal |
| 50 | Acute Kidney Injury | 107 | 3.7 | 3.8 | signal |
| 51 | Cerebral Haemorrhage | 25 | 3.7 | 3.7 | signal |
| 52 | Emphysema | 7 | 3.7 | 3.7 | signal |
| 53 | Circumstance Or Information Capable Of Leading To Medication Error | 23 | 3.6 | 3.7 | signal |
| 54 | Product Taste Abnormal | 9 | 3.6 | 3.6 | signal |
| 55 | Renal Pain | 7 | 3.5 | 3.5 | signal |
| 56 | Nocturia | 8 | 3.5 | 3.5 | signal |
| 57 | Prescribed Underdose | 13 | 3.5 | 3.5 | signal |
| 58 | Nerve Compression | 6 | 3.5 | 3.5 | signal |
| 59 | Back Injury | 7 | 3.4 | 3.4 | signal |
| 60 | Drug Dispensing Error | 10 | 3.4 | 3.4 | signal |
| 61 | Intervertebral Disc Degeneration | 6 | 3.4 | 3.4 | signal |
| 62 | Spinal Disorder | 6 | 3.4 | 3.4 | signal |
| 63 | Skin Haemorrhage | 9 | 3.3 | 3.3 | signal |
| 64 | Type 2 Diabetes Mellitus | 21 | 3.3 | 3.3 | signal |
| 65 | Hypokinesia | 9 | 3.3 | 3.3 | signal |
| 66 | Throat Irritation | 27 | 3.2 | 3.2 | signal |
| 67 | Haematochezia | 33 | 3.2 | 3.2 | signal |
| 68 | Blood Potassium Decreased | 18 | 3.2 | 3.2 | signal |
| 69 | Drug Effect Incomplete | 22 | 3.2 | 3.2 | signal |
| 70 | Subarachnoid Haemorrhage | 6 | 3.1 | 3.1 | signal |
| 71 | Poor Quality Product Administered | 6 | 3.1 | 3.1 | signal |
| 72 | Inappropriate Schedule Of Drug Administration | 42 | 3.1 | 3.1 | signal |
| 73 | Contusion | 55 | 3.0 | 3.1 | signal |
| 74 | Myocardial Infarction | 100 | 3.0 | 3.1 | signal |
| 75 | Contraindicated Product Administered | 17 | 3.0 | 3.0 | signal |
| 76 | Muscle Tightness | 9 | 3.0 | 3.0 | signal |
| 77 | Back Disorder | 9 | 2.9 | 2.9 | signal |
| 78 | Pulmonary Thrombosis | 6 | 2.9 | 2.9 | signal |
| 79 | Limb Discomfort | 17 | 2.9 | 2.9 | signal |
| 80 | Impaired Gastric Emptying | 7 | 2.9 | 2.9 | signal |
| 81 | Product Packaging Issue | 5 | 2.9 | 2.9 | signal |
| 82 | Knee Arthroplasty | 11 | 2.8 | 2.8 | signal |
| 83 | Musculoskeletal Disorder | 10 | 2.8 | 2.8 | signal |
| 84 | Gastric Disorder | 18 | 2.7 | 2.8 | signal |
| 85 | Knee Operation | 5 | 2.7 | 2.7 | no signal |
| 86 | Gingival Bleeding | 7 | 2.7 | 2.7 | signal |
| 87 | Coronary Artery Occlusion | 7 | 2.7 | 2.7 | signal |
| 88 | Blood Triglycerides Increased | 9 | 2.7 | 2.7 | signal |
| 89 | Sinus Disorder | 10 | 2.7 | 2.7 | signal |
| 90 | Ischaemic Stroke | 9 | 2.7 | 2.7 | signal |
| 91 | Bladder Disorder | 5 | 2.7 | 2.7 | no signal |
| 92 | Aphonia | 7 | 2.7 | 2.7 | signal |
| 93 | Transient Ischaemic Attack | 17 | 2.7 | 2.7 | signal |
| 94 | Tinnitus | 23 | 2.7 | 2.7 | signal |
| 95 | Haematoma | 13 | 2.7 | 2.7 | signal |
| 96 | Chronic Obstructive Pulmonary Disease | 26 | 2.6 | 2.7 | signal |
| 97 | Carpal Tunnel Syndrome | 7 | 2.6 | 2.7 | signal |
| 98 | Full Blood Count Decreased | 10 | 2.6 | 2.6 | signal |
| 99 | Nervousness | 26 | 2.6 | 2.6 | signal |
| 100 | Dry Throat | 5 | 2.6 | 2.6 | no signal |
| 101 | Lip Swelling | 16 | 2.6 | 2.6 | signal |
| 102 | Rhinorrhoea | 31 | 2.6 | 2.6 | signal |
| 103 | Musculoskeletal Pain | 25 | 2.5 | 2.5 | signal |
| 104 | Cataract | 28 | 2.5 | 2.5 | signal |
| 105 | Glaucoma | 9 | 2.5 | 2.5 | signal |
| 106 | Cerebrovascular Accident | 79 | 2.5 | 2.5 | signal |
| 107 | Flatulence | 26 | 2.4 | 2.4 | signal |
| 108 | Kidney Infection | 9 | 2.4 | 2.4 | signal |
| 109 | Pain In Jaw | 13 | 2.4 | 2.4 | signal |
| 110 | Intervertebral Disc Protrusion | 10 | 2.4 | 2.4 | signal |
| 111 | Delusion | 7 | 2.4 | 2.4 | signal |
| 112 | Underdose | 33 | 2.4 | 2.4 | signal |
| 113 | Product Physical Issue | 9 | 2.4 | 2.4 | signal |
| 114 | Ankle Fracture | 7 | 2.4 | 2.4 | signal |
| 115 | Pharyngeal Oedema | 7 | 2.4 | 2.4 | signal |
| 116 | Drug Effective For Unapproved Indication | 13 | 2.4 | 2.4 | signal |
| 117 | Limb Injury | 12 | 2.4 | 2.4 | signal |
| 118 | Restless Legs Syndrome | 8 | 2.3 | 2.3 | signal |
| 119 | Respiratory Arrest | 12 | 2.3 | 2.3 | signal |
| 120 | Irritable Bowel Syndrome | 9 | 2.2 | 2.2 | signal |
| 121 | Anaphylactic Reaction | 23 | 2.2 | 2.2 | signal |
| 122 | Skin Cancer | 9 | 2.2 | 2.2 | signal |
| 123 | Angina Pectoris | 12 | 2.2 | 2.2 | signal |
| 124 | Swollen Tongue | 13 | 2.2 | 2.2 | signal |
| 125 | Hernia | 8 | 2.2 | 2.2 | signal |
| 126 | Hemiparesis | 7 | 2.2 | 2.2 | no signal |
| 127 | Application Site Pain | 9 | 2.2 | 2.2 | signal |
| 128 | Tendon Rupture | 5 | 2.1 | 2.1 | no signal |
| 129 | Colon Cancer | 6 | 2.1 | 2.1 | no signal |
| 130 | Brain Injury | 4 | 2.1 | 2.1 | no signal |
| 131 | Chromaturia | 9 | 2.1 | 2.1 | signal |
| 132 | Fluid Retention | 20 | 2.1 | 2.1 | signal |
| 133 | Initial Insomnia | 4 | 2.1 | 2.1 | no signal |
| 134 | Eye Discharge | 4 | 2.1 | 2.1 | no signal |
| 135 | Rotator Cuff Syndrome | 5 | 2.1 | 2.1 | no signal |
| 136 | Toothache | 7 | 2.1 | 2.1 | no signal |
| 137 | Incorrect Dose Administered | 87 | 2.1 | 2.1 | signal |
| 138 | Scratch | 4 | 2.1 | 2.1 | no signal |
| 139 | Wrong Technique In Product Usage Process | 78 | 2.1 | 2.1 | signal |
| 140 | Immune System Disorder | 5 | 2.0 | 2.0 | no signal |
| 141 | Blood Glucose Abnormal | 7 | 2.0 | 2.0 | no signal |
| 142 | Incorrect Product Storage | 5 | 2.0 | 2.0 | no signal |
| 143 | Localised Infection | 9 | 2.0 | 2.0 | no signal |
| 144 | Throat Tightness | 10 | 2.0 | 2.0 | no signal |
| 145 | Feeling Jittery | 7 | 1.9 | 1.9 | no signal |
| 146 | Renal Injury | 11 | 1.9 | 1.9 | no signal |
| 147 | Bipolar Disorder | 4 | 1.9 | 1.9 | no signal |
| 148 | Prescribed Overdose | 7 | 1.9 | 1.9 | no signal |
| 149 | Prostatic Specific Antigen Increased | 5 | 1.9 | 1.9 | no signal |
| 150 | Oral Discomfort | 5 | 1.9 | 1.9 | no signal |
| 151 | Anaphylactic Shock | 9 | 1.9 | 1.9 | no signal |
| 152 | Hip Fracture | 11 | 1.8 | 1.8 | no signal |
| 153 | Product Quality Issue | 46 | 1.8 | 1.8 | no signal |
| 154 | Fluid Overload | 5 | 1.8 | 1.8 | no signal |
| 155 | Cardiac Failure Congestive | 27 | 1.8 | 1.8 | no signal |
| 156 | Blood Glucose Decreased | 16 | 1.8 | 1.8 | no signal |
| 157 | Spinal Operation | 4 | 1.8 | 1.8 | no signal |
| 158 | Thyroid Cancer | 4 | 1.8 | 1.8 | no signal |
| 159 | Cardiac Disorder | 31 | 1.8 | 1.8 | no signal |
| 160 | Impaired Work Ability | 7 | 1.7 | 1.7 | no signal |
| 161 | Extra Dose Administered | 13 | 1.7 | 1.7 | no signal |
| 162 | Thyroid Disorder | 5 | 1.7 | 1.7 | no signal |
| 163 | Drug Dose Omission | 54 | 1.7 | 1.7 | no signal |
| 164 | Thinking Abnormal | 6 | 1.7 | 1.7 | no signal |
| 165 | Basal Cell Carcinoma | 5 | 1.7 | 1.7 | no signal |
| 166 | Deformity | 3 | 1.7 | 1.7 | no signal |
| 167 | Pruritus Generalised | 7 | 1.7 | 1.7 | no signal |
| 168 | Laceration | 3 | 1.7 | 1.7 | no signal |
| 169 | Cardiovascular Disorder | 8 | 1.7 | 1.7 | no signal |
| 170 | Drug Effect Decreased | 17 | 1.7 | 1.7 | no signal |
| 171 | Sleep Disorder Due To A General Medical Condition | 5 | 1.6 | 1.6 | no signal |
| 172 | Application Site Erythema | 8 | 1.6 | 1.6 | no signal |
| 173 | Product Odour Abnormal | 3 | 1.5 | 1.5 | no signal |
| 174 | Local Swelling | 5 | 1.5 | 1.5 | no signal |
| 175 | Vaginal Haemorrhage | 12 | 1.5 | 1.5 | no signal |
| 176 | Drug Administered At Inappropriate Site | 3 | 1.5 | 1.5 | no signal |
| 177 | Abasia | 7 | 1.5 | 1.5 | no signal |
| 178 | Pulmonary Arterial Hypertension | 4 | 1.5 | 1.5 | no signal |
| 179 | Injection Site Nodule | 3 | 1.5 | 1.5 | no signal |
| 180 | Application Site Pruritus | 6 | 1.4 | 1.4 | no signal |
| 181 | Blood Count Abnormal | 4 | 1.4 | 1.4 | no signal |
| 182 | Procedural Pain | 7 | 1.3 | 1.3 | no signal |
| 183 | Intentional Overdose | 16 | 1.3 | 1.3 | no signal |
| 184 | Activities Of Daily Living Impaired | 5 | 1.3 | 1.3 | no signal |
| 185 | Product Dose Omission | 16 | 1.3 | 1.3 | no signal |
| 186 | Glycosylated Haemoglobin Increased | 6 | 1.3 | 1.3 | no signal |
| 187 | Intentional Drug Misuse | 5 | 1.3 | 1.3 | no signal |
| 188 | Injection Site Induration | 3 | 1.2 | 1.2 | no signal |
| 189 | Multiple Sclerosis | 11 | 1.2 | 1.2 | no signal |
| 190 | Device Malfunction | 15 | 1.2 | 1.2 | no signal |
| 191 | Application Site Rash | 3 | 1.2 | 1.2 | no signal |
| 192 | Abnormal Dreams | 6 | 1.1 | 1.1 | no signal |
| 193 | Blood Glucose Increased | 39 | 1.1 | 1.1 | no signal |
| 194 | Injection Site Haemorrhage | 16 | 1.1 | 1.1 | no signal |
| 195 | Menorrhagia | 4 | 1.1 | 1.1 | no signal |
| 196 | Psoriatic Arthropathy | 8 | 1.1 | 1.1 | no signal |
| 197 | Lung Neoplasm Malignant | 8 | 1.0 | 1.0 | no signal |
| 198 | Injection Site Bruising | 15 | 1.0 | 1.0 | no signal |
| 199 | Wrong Technique In Drug Usage Process | 7 | 1.0 | 1.0 | no signal |
| 200 | Product Dispensing Error | 4 | 1.0 | 1.0 | no signal |
| 201 | Plasma Cell Myeloma | 7 | 1.0 | 1.0 | no signal |
| 202 | Psoriasis | 23 | 0.9 | 0.9 | no signal |
| 203 | Injection Site Swelling | 13 | 0.9 | 0.9 | no signal |
| 204 | Injection Site Urticaria | 4 | 0.9 | 0.9 | no signal |
| 205 | Injection Site Pain | 50 | 0.9 | 0.9 | no signal |
| 206 | Product Complaint | 4 | 0.9 | 0.9 | no signal |
| 207 | Incorrect Dose Administered By Device | 4 | 0.8 | 0.8 | no signal |
| 208 | Drug Dependence | 24 | 0.8 | 0.8 | no signal |
| 209 | Product Preparation Error | 3 | 0.8 | 0.8 | no signal |
| 210 | Multiple Sclerosis Relapse | 10 | 0.8 | 0.8 | no signal |
| 211 | Device Leakage | 6 | 0.8 | 0.8 | no signal |
| 212 | Pancreatic Carcinoma | 4 | 0.7 | 0.7 | no signal |
| 213 | Injection Site Mass | 5 | 0.7 | 0.7 | no signal |
| 214 | Wrong Technique In Device Usage Process | 6 | 0.7 | 0.7 | no signal |
| 215 | Hepatic Cancer | 3 | 0.7 | 0.7 | no signal |
| 216 | Injection Site Pruritus | 7 | 0.6 | 0.6 | no signal |
| 217 | Accidental Exposure To Product | 10 | 0.5 | 0.5 | no signal |
| 218 | Breast Cancer | 9 | 0.5 | 0.5 | no signal |
| 219 | Device Issue | 8 | 0.5 | 0.5 | no signal |
| 220 | Product Adhesion Issue | 3 | 0.4 | 0.4 | no signal |
| 221 | Renal Cancer | 4 | 0.4 | 0.4 | no signal |
| 222 | Device Difficult To Use | 4 | 0.3 | 0.3 | no signal |